Company page

Aim Immunotech Inc.

Aim Immunotech Inc. is a public company traded under the ticker AIM in the American market. With a market capitalization of approximately $6.9 million, the company is focused on developing innovative immunotherapy solutions. Aim Immunotech is committed to advancing its research and product offerings in the biotechnology sector.